Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Tonix pharmaceuticals holding corp. crawled time : 12:01 save search
Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)
Published: 2021-02-11 (Crawled : 12:01) - globenewswire.com
TNXP | $0.16 2.04% 1.2% 940K
|
Health Technology
|
| O: 9.2%
H: 19.1%
C: 12.36%
genetic license research syndros rare
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
Published: 2020-12-22 (Crawled : 12:01) - globenewswire.com
TNXP | $0.16 2.04% 1.2% 940K
|
Health Technology
|
| O: 3.05%
H: 1.28%
C: -2.74%
diabetes obesity license oxytocin insulin potential
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.